Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Por Kaye, K M, Izumi, K M, Kieff, E
Publicado em 1993

Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary...

Por Izumi, K M, Kaye, K M, Kieff, E D
Publicado em 1994

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal...

Por Kaye, K M, Izumi, K M, Mosialos, G, Kieff, E
Publicado em 1995

Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing).

Por Kaye, K M, Spriggs, D R, Bassel-Duby, R, Fields, B N, Tyler, K L
Publicado em 1986

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.

Por Kaye, K M, Devergne, O, Harada, J N, Izumi, K M, Yalamanchili, R, Kieff, E, Mosialos, G
Publicado em 1996

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Por Devergne, O, Hatzivassiliou, E, Izumi, K M, Kaye, K M, Kleijnen, M F, Kieff, E, Mosialos, G
Publicado em 1996